Skip to main content
Bio-Gate AG logo

Bio-Gate AG — Investor Relations & Filings

Ticker · BIG1 ISIN · DE000BGAG981 LEI · 391200G5LKTIOTZOXP90 F Manufacturing
Open in API
Filings indexed 242 across all filing types
Latest filing 2026-05-20 Earnings Release
Country DE Germany
Listing F BIG1

About Bio-Gate AG

https://www.bio-gate.de/en/

Bio-Gate AG is a provider of innovative technologies and customized solutions for health and hygiene, specializing in antimicrobial and antiviral strategies. The company enhances materials and products by incorporating its unique silver-based technologies, such as MicroSilver BG™. Key applications are concentrated in the medical technology sector, including the coating of medical implants and wound dressings to prevent infections. The company's technologies are also utilized in derma-cosmetics and veterinary care products. Furthermore, Bio-Gate provides solutions for industrial and consumer goods, imparting antimicrobial properties to items like paints, coatings, plastics, and textiles.

Recent filings

Filing Released Lang Actions
Bio-Gate AG steigert im Geschaftsjahr 2025 den Umsatz und nahert sich operativem Break-even
Earnings Release Classification · 90% confidence The document is a corporate press release summarizing full-year 2025 financial results (revenue, EBITDA, EBIT, EPS) and outlook, with key highlights rather than the full annual report. It provides substantive financial metrics but is a concise earnings announcement. This matches an Earnings Release. FY 2025
2026-05-20 German
Bio-Gate AG: Einberufung ordentliche Hauptversammlung u.a. zum Zweck eines Kapitalschnitts mit vereinfachter Kapitalherabsetzung und anschlieender Barkapitalerhohung mit Bezugsrecht
Proxy Solicitation & Information Statement Classification · 82% confidence The document is an Ad-hoc announcement under EU Market Abuse Regulation notifying shareholders of the convening of the ordinary Annual General Meeting, outlining the agenda item to propose a capital reduction and subsequent capital increase with subscription rights. This is not the full AGM materials or results, nor a direct financial report. It is a proxy solicitation/information statement to inform and request votes at the meeting. Therefore, it matches the Proxy Solicitation & Information Statement category (PSI).
2026-05-18 German
Bio-Gate AG steigert im Geschaftsjahr 2025 den Umsatz und begrenzt den Verlust
Earnings Release Classification · 85% confidence The document is a corporate press release dated 20 April 2026 that provides preliminary, unaudited full‐year financial results for 2025 (revenue increase, loss mitigation, key metrics). It is not the full Annual Report (10-K) nor an Interim Report (which covers half‐year or quarterly detailed disclosures). It contains key highlights of periodical financial performance, typical of an Earnings Release. Therefore, the correct classification is ER (Earnings Release). FY 2025
2026-04-20 German
Jahresabschluss zum Geschäftsjahr vom 01.01.2024 bis zum 31.12.2024
Annual Report Classification · 100% confidence The document is a formal 'Jahresabschluss' (Annual Financial Statement) for Bio-Gate AG for the fiscal year 2024. It includes a balance sheet (Bilanz) and detailed notes (Anhang) covering accounting principles, valuation methods, and specific breakdowns of equity, provisions, and liabilities. As it contains the full financial statements for the fiscal year, it is classified as an Annual Report (10-K equivalent in this context). FY 2024
2026-02-10 German
Bio-Gate AG beschliet und platziert Barkapitalerhohung
Share Issue/Capital Change Classification · 100% confidence The document is an 'Ad-hoc' announcement regarding a capital increase (Barkapitalerhöhung) by Bio-Gate AG. It details the issuance of new shares, the exclusion of subscription rights, and the purpose of the funding. This falls under the category of share issuance and capital changes.
2025-10-29 German
Bio-Gate veroffentlicht Halbjahreszahlen und bestatigt den Ausblick fur 2025
Report Publication Announcement Classification · 100% confidence The document is a corporate news release from Bio-Gate AG announcing their half-year financial results for 2025. It provides a summary of key financial highlights (revenue, EBITDA, net income) and business developments. Crucially, the text explicitly states at the end of the main body that 'The full half-year report 2025 is available on the homepage of Bio-Gate AG', indicating that this document is an announcement of the report rather than the full report itself. According to the 'Menu vs Meal' rule, this classifies it as a Report Publication Announcement (RPA).
2025-09-30 German

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.